Heartburn Drugs Linked to Stomach Cancer & Heart Disease

antacidsAnother study has linked commonly prescribed heartburn drugs to fatal health conditions. This isn’t the first time that research has shown that these drugs have serious side effects. Also linked to liver disease and kidney disease, it may be time to reconsider popping those antacids and looking for an alternative. The class of drugs that were looked at is called proton pump inhibitors (PPIs). These are commonly prescribed to treat gastrointestinal conditions that involve an excess of acid production. Nexium, Aciphex, Zegerid, Dexilant, Prevacid, Prilosec, and Protonix are only some of the brand names that PPIs have taken over the years. Continue reading “Heartburn Drugs Linked to Stomach Cancer & Heart Disease”

Read More

Heartburn Drugs Linked to Liver Disease

heart-burnIt seems new studies about proton pump inhibitors (PPIs) and their side effects come out every few months. Just over a year ago, a study linking them to kidney disease came out. And earlier in the same year, a link between PPIs and dementia was made. This week, a study was published where researchers from the University of California San Diego School of Medicine found a link between PPI use and chronic liver disease.

Proton pump inhibitors are a popular class of heartburn medications that includes Prilosec, Nexium and Prevacid. These medications, which are available over-the-counter (without a prescription), Continue reading “Heartburn Drugs Linked to Liver Disease”

Read More

Proton Pump Inhibitors Linked to Kidney Disease

sick-manAnother reason to be wary of antacids. Research published online in the Journal of the American Society of Nephrology found that patients who regularly use proton pump inhibitors (PPIs) may be at increased risk of developing chronic kidney disease.

The new study findings are based on medical records from 173,321 Veterans Affairs patients who were prescribed a PPI and 20,270 other patients prescribed a histamine H2-receptor antagonist (H2-blocker). Over 5 years of follow-up, the results showed that 15% of people using PPIs were diagnosed with chronic kidney disease, versus 11% of those on H2-blockers. After the researchers weighed other factors, PPI users still had a 28% greater risk. Continue reading “Proton Pump Inhibitors Linked to Kidney Disease”

Read More

Our Bloggers

  • Paula Gallagher
    Paula Gallagher
    Paula is a highly qualified and experienced nutrition counselor on the staff at Village Green.
    read more..
  • Margo Gladding
    Margo Gladding
    Margo's impressive knowledge base is the result of a unique blend of educational and professional experience.
    read more..
  • Dr. Neal Barnard
    Dr. Neal Barnard
    Dr. Barnard leads programs advocating for preventive medicine, good nutrition, and higher ethical standards in research.
    read more..
  • Joseph Pizzorno
    Dr. Joseph Pizzorno
    Dr. Joseph Pizzorno, ND is a pioneer of integrative medicine and a leading authority on science-based natural medicine.
    read more..
  • Debi Silber
    Debi Silber
    Debi is a registered dietitian with a master’s degree in nutrition, a personal trainer, and whole health coach.
    read more..
  • Teri Cochrane
    Teri Cochrane
    Teri is a is a Certified Coach Practitioner with extensive certifications and experience in holistic medicinal practices.
    read more..
  • Dr. Rav Ivker
    Dr. Rav Ivker
    Dr. Rav Ivker is a holistic family physician, health educator, and best-selling author.
    read more..
  • Susan Levin
    Susan Levin
    Susan writes about the connection between plant-based diets and a reduced risk of chronic diseases.
    read more..
  • Rob Brown
    Dr. Rob Brown
    Dr. Brown's blended perspective of healthcare includes a deeply rooted passion for wellness and spiritual exploration.
    read more..
April 2024
S M T W T F S
 123456
78910111213
14151617181920
21222324252627
282930